ML17310A366: Difference between revisions
StriderTol (talk | contribs) (Created page by program invented by StriderTol) |
StriderTol (talk | contribs) (Created page by program invented by StriderTol) |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 16: | Line 16: | ||
=Text= | =Text= | ||
{{#Wiki_filter: | {{#Wiki_filter:November 16, 2017 Ms. Carolyn Haass Chief Operating Officer Northwest Medical Isotopes, LLC 815 Northwest 9th Street, Suite 256 Corvallis, OR 97330 | ||
November 16, 2017 | |||
Ms. Carolyn Haass Chief Operating Officer Northwest Medical Isotopes, LLC 815 Northwest 9th Street, Suite 256 Corvallis, OR | |||
==SUBJECT:== | ==SUBJECT:== | ||
SAFETY EVALUATION REPORT FOR THE NORTHWEST MEDICAL ISOTOPES, LLC, CONSTRUCTION PERMIT APPLICATION | SAFETY EVALUATION REPORT FOR THE NORTHWEST MEDICAL ISOTOPES, LLC, CONSTRUCTION PERMIT APPLICATION | ||
==Dear Ms. Haass:== | ==Dear Ms. Haass:== | ||
This letter is to inform you that the U.S. Nuclear Regulatory Commission (NRC) staff has completed the safety evaluation report (SER) for the Northwest Medical Isotopes, LLC (NWMI) construction permit application. | This letter is to inform you that the U.S. Nuclear Regulatory Commission (NRC) staff has completed the safety evaluation report (SER) for the Northwest Medical Isotopes, LLC (NWMI) construction permit application. NWMIs application was submitted in two parts, by letters dated February 5, 2015 (Agencywide Documents Access and Management System (ADAMS) | ||
Accession No. ML15086A261), and July 20, 2015 (ADAMS Accession No. ML15210A182), as supplemented by letters dated September 8, 2017 (ADAMS Accession No. ML17257A019), | |||
The enclosed SER is being provided to NWMI for your information and will be submitted to the Commission in preparation for the mandatory (uncontested) hearing, scheduled for January 23, 2018. The SER has also been placed in the public document room and has been made publicly available in ADAMS under Accession No. ML17310A368. The NRC staff issuance of this SER does not constitute a commitment to issue the construction permit, or in any way affect the authority of the Commission in any mandatory hearing proceeding pursuant to Title 10 of the Code of Federal Regulations Section 50.58, | September 18, 2017 (ADAMS Accession No. ML17265A048), and September 28, 2017 (ADAMS Accession No. ML17283A109). | ||
Louise Lund, Director Division of Licensing Projects Office of Nuclear Reactor Regulation | The enclosed SER is being provided to NWMI for your information and will be submitted to the Commission in preparation for the mandatory (uncontested) hearing, scheduled for January 23, 2018. The SER has also been placed in the public document room and has been made publicly available in ADAMS under Accession No. ML17310A368. The NRC staff issuance of this SER does not constitute a commitment to issue the construction permit, or in any way affect the authority of the Commission in any mandatory hearing proceeding pursuant to Title 10 of the Code of Federal Regulations Section 50.58, Hearings and report of the Advisory Committee on Reactor Safeguards. | ||
Sincerely, | |||
Docket No. 50-609 | /RA Mary Jane Ross-Lee Acting for/ | ||
Louise Lund, Director Division of Licensing Projects Office of Nuclear Reactor Regulation Docket No. 50-609 | |||
==Enclosure:== | ==Enclosure:== | ||
As stated | As stated | ||
ML17310A365 (Pkg.); ML17310A366 (Letter); ML17310A368 (SER) *via e-mail OFFICE NRR/DLP/PRLB/PM NRR/DLP/PRLB/LA* Tech Editor NMSS/FCSE/FMB/PM NMSS/FCSE/FMB/BC NAME MBalazik NParker* CAmoruso DTiktinsky RJohnson (DTiktinsky for) DATE 11/7/17 11/6/17 11/14/2017 11/7/17 11/7/17 OFFICE NRR/DLP/PRLB/BC OGC NMSS/ | ML17310A365 (Pkg.); ML17310A366 (Letter); ML17310A368 (SER) *via e-mail OFFICE NRR/DLP/PRLB/PM NRR/DLP/PRLB/LA* Tech Editor NMSS/FCSE/FMB/PM NMSS/FCSE/FMB/BC NAME MBalazik NParker* CAmoruso DTiktinsky RJohnson (DTiktinsky for) | ||
}} | DATE 11/7/17 11/6/17 11/14/2017 11/7/17 11/7/17 OFFICE NRR/DLP/PRLB/BC OGC NMSS/FCS NRR/DLP/D E/D* | ||
NAME AAdams MYoung/w NLO CErlanger LLund (BSmith for) (MJRoss-Lee for) | |||
DATE 11/7/17 11/14/17 11/13/17 11/16/ 2017}} | |||
Latest revision as of 08:33, 29 October 2019
| ML17310A366 | |
| Person / Time | |
|---|---|
| Site: | Northwest Medical Isotopes |
| Issue date: | 11/16/2017 |
| From: | Louise Lund Research and Test Reactors Licensing Projects Branch |
| To: | Haass C Northwest Medical Isotopes |
| Balazik M, NRR/DLP, 415-2856 | |
| Shared Package | |
| ML17310A365 | List: |
| References | |
| Download: ML17310A366 (2) | |
Text
November 16, 2017 Ms. Carolyn Haass Chief Operating Officer Northwest Medical Isotopes, LLC 815 Northwest 9th Street, Suite 256 Corvallis, OR 97330
SUBJECT:
SAFETY EVALUATION REPORT FOR THE NORTHWEST MEDICAL ISOTOPES, LLC, CONSTRUCTION PERMIT APPLICATION
Dear Ms. Haass:
This letter is to inform you that the U.S. Nuclear Regulatory Commission (NRC) staff has completed the safety evaluation report (SER) for the Northwest Medical Isotopes, LLC (NWMI) construction permit application. NWMIs application was submitted in two parts, by letters dated February 5, 2015 (Agencywide Documents Access and Management System (ADAMS)
Accession No. ML15086A261), and July 20, 2015 (ADAMS Accession No. ML15210A182), as supplemented by letters dated September 8, 2017 (ADAMS Accession No. ML17257A019),
September 18, 2017 (ADAMS Accession No. ML17265A048), and September 28, 2017 (ADAMS Accession No. ML17283A109).
The enclosed SER is being provided to NWMI for your information and will be submitted to the Commission in preparation for the mandatory (uncontested) hearing, scheduled for January 23, 2018. The SER has also been placed in the public document room and has been made publicly available in ADAMS under Accession No. ML17310A368. The NRC staff issuance of this SER does not constitute a commitment to issue the construction permit, or in any way affect the authority of the Commission in any mandatory hearing proceeding pursuant to Title 10 of the Code of Federal Regulations Section 50.58, Hearings and report of the Advisory Committee on Reactor Safeguards.
Sincerely,
/RA Mary Jane Ross-Lee Acting for/
Louise Lund, Director Division of Licensing Projects Office of Nuclear Reactor Regulation Docket No. 50-609
Enclosure:
As stated
ML17310A365 (Pkg.); ML17310A366 (Letter); ML17310A368 (SER) *via e-mail OFFICE NRR/DLP/PRLB/PM NRR/DLP/PRLB/LA* Tech Editor NMSS/FCSE/FMB/PM NMSS/FCSE/FMB/BC NAME MBalazik NParker* CAmoruso DTiktinsky RJohnson (DTiktinsky for)
DATE 11/7/17 11/6/17 11/14/2017 11/7/17 11/7/17 OFFICE NRR/DLP/PRLB/BC OGC NMSS/FCS NRR/DLP/D E/D*
NAME AAdams MYoung/w NLO CErlanger LLund (BSmith for) (MJRoss-Lee for)
DATE 11/7/17 11/14/17 11/13/17 11/16/ 2017